Marathon Digital Plans $250M Convertible Debt Saleby John Darbie 14.08.2024Marathon Digital aims to raise $250M through convertible notes for Bitcoin purchases and corporate uses.
IO Biotech Exceeds Q2 2024 EPS Expectationsby Lilu Anderson 14.08.2024IO Biotech's Q2 2024 EPS beats estimates, reporting -31 cents vs. expected -35 cents, despite no revenue.
PDS Biotech’s Q2 2024 Update: Clinical Progressby Lilu Anderson 13.08.2024PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
AI Predicted to Boost Returns in Biotech Stocksby Lilu Anderson 13.08.2024AI integration in biotech could reduce R&D costs, enhance efficiency, and increase returns for investors.
Finance Experts Warn of Social Unrest Risksby Mark Eisenberg 12.08.2024Discover why finance veterans foresee social unrest as a major risk due to economic disparities and global trends.
Legend Biotech’s Q2 2024 Earnings: Growth & Strategyby Lilu Anderson 12.08.2024Legend Biotech reports significant revenue growth in Q2 2024, with strategic advancements in CAR-T therapies.
Standard Chartered Restructures Investment Banking Teamby Mark Eisenberg 12.08.2024Standard Chartered reorganizes to streamline operations, folding industry coverage into M&A, eliminating over 20 roles.
LL Flooring Files for Chapter 11 Bankruptcyby Mark Eisenberg 12.08.2024LL Flooring seeks court approval for sale amid bankruptcy, securing $130M financing while negotiating with bidders.
InspireMD Eyes US Launch Amid Revenue Growthby Mark Eisenberg 11.08.2024InspireMD reports revenue growth in Q2 2024 and plans to launch CGuard Prime in the US by 2025, despite current ...
Wintrust Financial Q2 2024 Earnings Highlightby Mark Eisenberg 11.08.2024Wintrust's Q2 2024 EPS falls short, revenue aligns with forecasts. Shares dip as net income declines by 1.6% from last ...